Which companies participated in the new share allotment that funded SIRUTAS Inc.'s recent expansion?

The allotment included Nisshin Oillio Group Ltd. and existing shareholder giftee Inc., both providing capital for SIRUTAS.

What is the annual amount of medical expenses in Japan that SIRUTAS cites as a driver for its preventive‑medicine approach?

Japan’s medical costs have exceeded 45 trillion yen each year, highlighting the need for preventive healthcare solutions.

What is the name of the platform SIRUTAS is developing to analyze supermarket purchase data for health insights?

SIRUTAS is developing a healthcare platform called SIRU+ that examines dietary habits, nutrition and buying behavior.

Where is SIRUTAS Inc. headquartered and who serves as its chief executive officer?

SIRUTAS Inc. is headquartered in Minato-ku, Tokyo, and its CEO is Kazuki Ohara.

How does the SIRU+ platform aim to promote healthy behavior through everyday shopping activities?

SIRU+ analyzes users' food preferences and purchasing tendencies, then recommends nutritionally balanced foods that they are likely to actually buy.

AI News NQ Analysis

SIRUTAS Raises Funds from Nisshin Oillio and giftee to Build 'Pre-disease Infrastructure' through Purchase Data & Nutritional Analysis

NQ Score 82/100

N1 Content Completeness 9

AI Summary (NQ-processed)

SIRUTAS Inc., developer of the healthcare app SIRU+, raised funds through a third-party allotment to Nisshin Oillio Group and giftee. They aim to combine purchase data with nutritional expertise to promote 'effortless healthcare'.

AI Analysis

Frequently Asked Questions

Q: Which companies participated in the new share allotment that funded SIRUTAS Inc.'s recent expansion?: A: The allotment included Nisshin Oillio Group Ltd. and existing shareholder giftee Inc., both providing capital for SIRUTAS.
Q: What is the annual amount of medical expenses in Japan that SIRUTAS cites as a driver for its preventive‑medicine approach?: A: Japan’s medical costs have exceeded 45 trillion yen each year, highlighting the need for preventive healthcare solutions.
Q: What is the name of the platform SIRUTAS is developing to analyze supermarket purchase data for health insights?: A: SIRUTAS is developing a healthcare platform called SIRU+ that examines dietary habits, nutrition and buying behavior.
Q: Where is SIRUTAS Inc. headquartered and who serves as its chief executive officer?: A: SIRUTAS Inc. is headquartered in Minato-ku, Tokyo, and its CEO is Kazuki Ohara.
Q: How does the SIRU+ platform aim to promote healthy behavior through everyday shopping activities?: A: SIRU+ analyzes users' food preferences and purchasing tendencies, then recommends nutritionally balanced foods that they are likely to actually buy.